Recapitulating SARS-CoV-2 Infection in a Human Lung Organoid-on-a-Chip at the Air-Liquid Interface
The study presents a human lung organoid-on-a-chip model that successfully recapitulates native airway complexity and reveals conserved SARS-CoV-2-induced epithelial remodeling and vascular angiogenic responses across multiple viral variants, offering a physiologically relevant platform for respiratory disease research.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human lung is a marvel of biological engineering, a vast network of delicate tubes and sacs designed to swap oxygen for carbon dioxide with every breath. To study how diseases like pneumonia or viral infections attack this system, scientists have long relied on two main tools: growing flat layers of cells in a dish or using animals. Flat layers are simple but miss the complex three-dimensional structure of real tissue, while animal models often fail to mimic the specific ways human cells react to pathogens. For decades, researchers have sought a middle ground: a model that captures the intricate architecture and behavior of the human lung in a test tube. Recently, a new generation of technology has emerged, combining tiny, fluid-filled devices known as "chips" with clusters of living cells that grow into miniature organs, or organoids. These systems aim to recreate the lung's unique environment, where air touches the surface of the cells while blood flows just beneath them, a setup that is critical for understanding how respiratory viruses invade and damage the body.
In a recent study, a team of researchers from South Korea built such a system to watch how the virus that causes COVID-19 interacts with human lung tissue. They created a "lung organoid-on-a-chip," a microfluidic device that holds a thin layer of human airway cells on top and a layer of blood vessel cells on the bottom. To make this model as realistic as possible, they grew the airway cells at an air-liquid interface, meaning the top of the cells was exposed to air while the bottom was bathed in fluid, mimicking the natural condition inside a human lung. They also added immune cells to the mix to see how the whole system responded. The researchers then introduced four different versions of the SARS-CoV-2 virus—the original strain and three later variants known as Delta, Omicron BA.1, and Omicron XBB.1—into the air space of their chip. By analyzing the genetic activity of thousands of individual cells after infection, they mapped exactly how the virus changed the behavior of the lung tissue.
The results revealed a consistent pattern of damage and defense across all four virus variants. When the virus entered the system, it caused a dramatic shift in the makeup of the airway cells. The cells responsible for sweeping mucus and debris out of the lungs, known as ciliated cells, largely disappeared. In their place, the number of basal cells, which act as stem cells capable of rebuilding tissue, increased significantly. This suggests that the virus injures the lung's protective lining, forcing the remaining cells to switch into a repair mode. At the same time, the infected cells showed a muted response to the virus's presence. Normally, when a cell detects an invader, it sounds an alarm by releasing interferon signals to rally the immune system. In this model, that alarm system was noticeably quieter than expected, a finding that aligns with the virus's known ability to hide from the body's early defenses.
The infection also triggered changes in the cells that line the blood vessels beneath the airway. These cells began to show signs of preparing for new blood vessel growth, a process called angiogenesis. The researchers observed an increase in cells that look like the leading tips of growing vessels and a rise in specific chemical signals that encourage this growth. Interestingly, this response did not rely on the usual chemical messenger, VEGF, but instead used a different set of signals, including a protein called ANGPT2. This specific pattern of vascular change mirrors what has been seen in the lungs of patients with severe COVID-19, where the blood vessels become leaky and disorganized. The study also noted that the presence of immune cells, specifically macrophages, seemed to help the virus enter the system more effectively, hinting at a complex interaction between the virus and the immune system that aids infection.
While the study was limited by the fact that it used only one sample for each condition, the patterns observed were strikingly consistent with what is known about the disease in real patients. The researchers did not find major differences in how the four virus variants affected the tissue; instead, they all produced the same core set of changes: the loss of protective ciliated cells, a dampened immune alarm, a shift toward a repair state in the airway, and a reorganization of the blood vessels. This consistency suggests that the lung organoid-on-a-chip is a reliable tool for studying the fundamental mechanics of SARS-CoV-2 infection. By capturing these high-resolution details of how the virus reshapes human lung tissue, the platform offers a powerful new way to test potential treatments and understand the disease without relying on animal models. The work demonstrates that it is possible to recreate the essential features of a human lung infection in a controlled laboratory setting, providing a clear window into the biological events that drive respiratory disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.